ORCID as entered in ROS

Select Publications
2017, 'Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells', in Nanomedicine in Cancer, Pan Stanford, pp. 297 - 316, http://dx.doi.org/10.1201/b22358-11
,, 2017, 'Chapter 10: Curcumin‒Loaded γ ‒Cyclodextrin Liposomal Nanoparticles as Delivery Vehicles for Osteosarcoma', in Dhule SS; Penfornis P; Frazier T; Walker R; Feldman J; Tan G; He J; Alb A; John V; Pochampally R (ed.), Nanomedicine in Cancer, CRC Press, pp. 265 - 296, http://dx.doi.org/10.1201/9781315114361-11
2017, 'Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells', in Balogh LP (ed.), Nanomedicine in Cancer, PAN STANFORD PUBLISHING PTE LTD, pp. 297 - 316
,2017, 'Physiological and clinical considerations of drug delivery systems containing carbon nanotubes and graphene', in Drug Delivery Approaches and Nanosystems Volume 2 Drug Targeting Aspects of Nanotechnology, pp. 205 - 224, http://dx.doi.org/10.1201/9781315225364
,2013, 'Polyphenol Conjugate: Synthesis and Potential Biomedical Applications', in Recent Advances in Drug Delivery Research, Nova Science Publishers, USA
,2012, 'Manipulation, Guidance and Tracking of Mesenchymal Stem Cells for Regenerative Medicine and Transplantation: The Role of Magnetic Nanoparticles', in Stem Cells and Cancer Stem Cells, Volume 7 Therapeutic Applications in Disease and Injury, Springer Science & Business Media
,2011, 'Imaging and Biomedical Application of Magnetic Carbon Nanotubes', in Naraghi M (ed.), CARBON NANOTUBES - GROWTH AND APPLICATIONS, INTECH EUROPE, pp. 189 - 210, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000371131400009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'Physical properties of carbon nanotubes for therapeutic applications', in Klingeler R; Sim RB (ed.), Carbon Nanostructures, pp. 3 - 26, http://dx.doi.org/10.1007/978-3-642-14802-6_1
,2025, 'Motor-Free Soft Robots for Cancer Detection, Surgery, and In Situ Bioprinting', Advanced Healthcare Materials, 14, http://dx.doi.org/10.1002/adhm.202404623
,2025, 'Abstract 2705: Spatial profiling of tumor microenvironment uncovers potential novel therapeutic approach in pediatric neuroblastoma', Cancer Research, 85, pp. 2705 - 2705, http://dx.doi.org/10.1158/1538-7445.am2025-2705
,2025, 'CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers', Oncogene, 44, pp. 893 - 908, http://dx.doi.org/10.1038/s41388-024-03259-y
,2025, 'Correction to: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers (Oncogene, (2025), 44, 13, (893-908), 10.1038/s41388-024-03259-y)', Oncogene, 44, pp. 927, http://dx.doi.org/10.1038/s41388-025-03319-x
,2025, 'Germline analysis of an international cohort of pediatric diffuse midline glioma patients.', Neuro Oncol, http://dx.doi.org/10.1093/neuonc/noaf061
,2025, 'Cuproplasia-related gene signature: Prognostic insights for glioma therapy', Neuro Oncology Advances, 7, http://dx.doi.org/10.1093/noajnl/vdae233
,2025, 'A phase 1 trial of the FACT inhibitor CBL0137 in pediatric patients with relapsed or refractory solid and CNS tumors: A report from the Children’s Oncology Group study PEPN2111.', Journal of Clinical Oncology, 43, pp. 10051 - 10051, http://dx.doi.org/10.1200/jco.2025.43.16_suppl.10051
,2025, 'Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.', Clin Transl Med, 15, pp. e70140, http://dx.doi.org/10.1002/ctm2.70140
,2025, 'Motor‐Free Soft Robots for Cancer Detection, Surgery, and In Situ Bioprinting (Adv. Healthcare Mater. 14/2025)', Advanced Healthcare Materials, 14, http://dx.doi.org/10.1002/adhm.202570083
,2024, 'Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma', Nature Communications, 15, pp. 10462, http://dx.doi.org/10.1038/s41467-024-54689-x
,2024, 'A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome', Human Genetics, 143, pp. 1145 - 1162, http://dx.doi.org/10.1007/s00439-024-02673-2
,2024, 'Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain', ACS Sensors, 9, pp. 2858 - 2868, http://dx.doi.org/10.1021/acssensors.3c02549
,2024, 'Dual-responsive chondroitin sulfate self-assembling nanoparticles for combination therapy in metastatic cancer cells', International Journal of Pharmaceutics X, 7, http://dx.doi.org/10.1016/j.ijpx.2024.100235
,2024, 'Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells', Nanoscale Horizons, 9, pp. 1211 - 1218, http://dx.doi.org/10.1039/d4nh00042k
,2024, 'Abstract 3056: Copper chelation modulates YTHDF2 RNA-binding protein localization and global translation, in neuronal cancers', Cancer Research, 84, pp. 3056 - 3056, http://dx.doi.org/10.1158/1538-7445.am2024-3056
,2024, 'Abstract 3636: Myeloid cell rebound associated with GD2-CAR-T cell therapy in solid tumor patients', Cancer Research, 84, pp. 3636 - 3636, http://dx.doi.org/10.1158/1538-7445.am2024-3636
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202300360
,2024, 'A road map for the treatment of pediatric diffuse midline glioma', Cancer Cell, 42, pp. 1 - 5, http://dx.doi.org/10.1016/j.ccell.2023.11.002
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery (Adv. Therap. 2/2024)', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202470003
,2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x
,2023, 'Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer', Cell and Bioscience, 13, pp. 132, http://dx.doi.org/10.1186/s13578-023-01083-7
,2023, 'Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation', Rsc Advances, 13, pp. 34045 - 34056, http://dx.doi.org/10.1039/d3ra06434d
,2023, 'Evaluating the Efficiency of Chitosan-Graphene Oxide Hybrid Hydrogels as Drug Delivery Systems', Macromolecular Materials and Engineering, 308, http://dx.doi.org/10.1002/mame.202300166
,2023, 'Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition', Cell Reports, 42, http://dx.doi.org/10.1016/j.celrep.2023.112616
,2023, 'Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm', Antibiotics, 12, pp. 585, http://dx.doi.org/10.3390/antibiotics12030585
,2023, 'Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient', Frontiers in Molecular Biosciences, 10, http://dx.doi.org/10.3389/fmolb.2023.1148501
,2022, 'GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma', Journal for Immunotherapy of Cancer, 10, http://dx.doi.org/10.1136/jitc-2022-005187
,2022, 'Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy', Nanomaterials, 12, http://dx.doi.org/10.3390/nano12162851
,2022, 'Curcumin and Graphene Oxide Incorporated into Alginate Hydrogels as Versatile Devices for the Local Treatment of Squamous Cell Carcinoma', Materials, 15, pp. 1648, http://dx.doi.org/10.3390/ma15051648
,2021, 'Tp53 mutation is a prognostic factor in lower grade glioma and may influence chemotherapy efficacy', Cancers, 13, pp. 5362, http://dx.doi.org/10.3390/cancers13215362
,2021, 'Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics', Chemmedchem, 16, pp. 2315 - 2329, http://dx.doi.org/10.1002/cmdc.202100172
,2021, 'Dextran‐curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells', International Journal of Molecular Sciences, 22, http://dx.doi.org/10.3390/ijms22137013
,2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, 35, pp. 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994
,2021, 'Alginate bioconjugate and graphene oxide in multifunctional hydrogels for versatile biomedical applications', Molecules, 26, pp. 1355, http://dx.doi.org/10.3390/molecules26051355
,2021, 'Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma', Cancers, 13, pp. 1 - 20, http://dx.doi.org/10.3390/cancers13061278
,2021, 'Carbon Nanohorns as Effective Nanotherapeutics in Cancer Therapy', C-JOURNAL OF CARBON RESEARCH, 7, http://dx.doi.org/10.3390/c7010003
,2020, 'DIPG-83. USING COPPER CHELATING AGENTS TO TARGET RECEPTOR TYROSINE KINASE SIGNALLING IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', Neuro-Oncology, 22, pp. iii303 - iii303, http://dx.doi.org/10.1093/neuonc/noaa222.124
,2020, 'Natural polysaccharide carriers in brain delivery: Challenge and perspective', Pharmaceutics, 12, http://dx.doi.org/10.3390/pharmaceutics12121183
,2020, 'Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion', Cancer Research, 80, pp. 4129 - 4144, http://dx.doi.org/10.1158/0008-5472.CAN-20-0471
,2020, 'Functionalized carbon nanostructures versus drug resistance: Promising scenarios in cancer treatment', Molecules, 25, http://dx.doi.org/10.3390/molecules25092102
,2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics, 10, pp. 6411 - 6429, http://dx.doi.org/10.7150/thno.42602
,2020, 'Dextran-curcumin nanoparticles as a methotrexate delivery vehicle: A step forward in breast cancer combination therapy', Pharmaceuticals, 13, pp. 2, http://dx.doi.org/10.3390/ph13010002
,